Perspective Therapeutics, Inc. — Income Charts
52 quarters of history · ending 2023-09-30 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue↑+27.3% +$468K
$2M
Cost of Revenue↑+11.1% +$144K
$1M
Gross Profit↑+78.3% +$324K
$738K
R&D↑+684.2% +$5M
$6M
D&A↑+286.6% +$192K
$259K
Operating Income↓-131.7% -$6M
$-10M
EBITDA↓-129.2% -$5M
$-9M
Interest Expense
$14K
Interest Income↑+45.7% +$64K
$204K
Other Income/Expense
$-12K
Pretax Income↓-135.3% -$6M
$-10M
Tax Provision
$0
Net Income↓-154.6% -$6M
$-10M
Gross Margin↑+9.7pts
33.8%
Operating Margin↓-201.1pts
-446.2%
Net Margin↓-237.0pts
-474.0%
Effective Tax Rate↑+0.0pts
0.0%
Deferred Tax Liabilities
—
ETR (Continuing Operations)
—
ETR Federal Statutory↑+0.0pts
21.0%
ETR State + Local (pp)
—
ETR Foreign Differential (pp)
—
Operating Lease Cost↑+153.2% +$121K
$200K
Revenue YoY Variation↑+60.3pts
27.3%
Income YoY Variation↓-46.7pts
-131.7%
Revenue QoQ Variation↑+36.1pts
4.6%
Income QoQ Variation↑+99.9pts
0.0%